NeuroBo Pharmaceuticals, Inc.

NASDAQ:NRBO

2.92 (USD) • At close October 21, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 000.00400000000000000000000000000000000000
Cost of Revenue 0.0060.0040.0040.00100.0010.0010.0020.0070.0120.0360.0120.0190.017000000000000000000000000
Gross Profit -0.006-0.0040-0.0010-0.001-0.001-0.002-0.007-0.012-0.036-0.012-0.019-0.017000000000000000000000000
Gross Profit Ratio 00000000000000000000000000000000000000
Reseach & Development Expenses 8.0744.9043.8612.2922.3640.6370.3050.5710.9820.921.9971.3942.0121.14317.7791.2650.6742.15213.781.0681.2341.3931.8333.5423.964.9775.086.4895.8375.284.8391.9360.7891.1761.4641.3690.9520.206
General & Administrative Expenses 2.011.9771.8021.6011.4421.8831.9152.5332.2371.9552.5812.071.9142.1871.7361.7951.7182.597-1.0711.251.1151.4071.4682.3642.5742.0871.4872.054.6782.2232.3891.4661.0511.051.0470.9970.6580.475
Selling & Marketing Expenses -0.006-0.004000000000000000000000000000000000000
SG&A 2.0041.9731.8021.6011.4421.8831.9152.5332.2371.9552.5812.071.9142.1871.7361.7951.7182.597-1.0711.251.1151.4071.4682.3642.5742.0871.4872.054.6782.2232.3891.4661.0511.051.0470.9970.6580.475
Other Expenses 000.0040000.01-0.009-0.0840000025.18500-0.00110.009-1.116-0.581-0.171-0.177-0.00100000000000000
Operating Expenses 10.0786.8775.6633.8933.8062.522.223.1043.2192.8754.5783.4643.9263.3319.5153.062.3924.74912.7092.3182.3492.83.3015.9066.5347.0646.5678.53910.5157.5037.2283.4021.842.2262.5112.3661.610.681
Operating Income -10.084-6.881-5.667-3.893-3.806-2.52-10.43-3.104-3.219-2.875-4.578-3.464-3.926-3.33-19.515-3.06-2.392-4.749-12.709-2.318-2.349-2.8-3.301-5.906-6.534-7.064-6.567-8.539-10.515-7.503-7.228-3.402-1.84-2.226-2.511-2.366-1.61-1.589
Operating Income Ratio 00-1,416.7500000000000000000000000000000000000
Total Other Income Expenses Net 0.0310.1670.3530.0753.072-0.0845.754-0.009-0.0840-10.7060.0030.0050.006-10.1630.0060.008-0.0010.754-1.116-0.581-0.171-0.177-0.001-0.144-0.16-0.179-0.1320.013-0.0050.001-0.0010.449-0.004-0.1960.006-0.001-0.908
Income Before Tax -10.053-6.714-5.314-3.818-0.734-2.604-4.676-3.113-3.303-2.875-4.578-3.461-3.921-3.324-19.51-3.054-2.384-4.73-11.161-3.43-2.92-3.801-3.656-6.079-6.678-7.224-6.746-8.671-10.502-7.496-7.214-3.878-1.391-2.103-2.57-2.569-1.611-2.279
Income Before Tax Ratio 00-1,328.500000000000000000000000000000000000
Income Tax Expense 0-0.039-0.083-0.001-3.1940.084-5.670.009-0.002010.7060-0.007-0.005-10.16800-0.02-0.806-0.008-0.011-1.6210.178-1.555-4.649-4.649000-0.01200.4750-0.127-0.1370.2090-0.218
Net Income -10.053-6.714-5.314-3.818-0.734-2.6880.994-3.122-3.303-2.875-4.578-3.461-3.921-3.324-19.51-3.054-2.384-4.73-11.161-3.43-2.92-3.801-3.656-6.079-6.678-7.224-6.746-8.671-10.502-7.496-7.214-3.878-1.391-2.103-2.57-2.569-1.611-2.279
Net Income Ratio 00-1,328.500000000000000000000000000000000000
EPS -1.85-1.32-1.05-0.75-0.15-0.530.31-3.51-3.72-3.24-6.16-4.66-5.35-4.61-35.63-5.58-4.39-9.06-193.47-19.92-16.95-199.84-192.22-319.75-351.92-435.55-475.84-612.19-742.87-590.52-584.08-416.5-113.63-171.79-363.61-363.47-227.93-322.44
EPS Diluted -1.85-1.32-1.05-0.75-0.15-0.530.31-3.51-3.72-3.23-6.16-4.66-5.35-4.61-35.63-5.58-4.39-9.06-193.47-19.92-16.95-199.84-192.22-319.75-351.92-435.55-475.84-612.19-742.87-590.52-584.08-416.5-113.63-171.79-363.56-363.47-227.93-322.44
EBITDA -10.078-6.877-5.663-3.893-6.878-2.435-2.577-3.102-3.214-2.863-4.566-3.452-3.914-3.318-19.503-3.049-2.385-4.733-12.709-2.318-2.349-2.8-3.478-5.906-6.534-7.064-6.567-8.539-10.515-7.498-7.228-3.401-1.84-2.222-2.315-2.372-1.6090.227
EBITDA Ratio 00-1,415.7500000000000000000000000000000000000